Waldenström Macroglobulinemia, An Issue of Hematology/Oncology Clinics of North America

by Jorge J Castillo, Efstathios Kastritis, Steven P Treon

Overview

This issue of Hematology/Oncology Clinics, edited by Drs. Jorge J. Castillo, Efstathios Kastritis, and Steven P. Treon, will focus on Waldenström Macroglobulinemia. Topics include, but are not limited to, Genomics; Epigenomics; Flow cytometry; Marrow microenvironment; Familial Waldenstrom; MYD88 L265P and other MYD88 mutations; CXCR4 and other recurrent mutations; Diagnosis and differential diagnosis; Criteria to treat and treatment goals; Alkylators; Monoclonal antibodies; Proteasome inhibitors; BTK inhibitors; Transplant; and Novel approaches.

Product Details

ISBN-13:	9780323641289
Publisher:	Elsevier Health Sciences
Publication date:	09/07/2018
Series:	The Clinics: Internal Medicine , #32
Sold by:	Barnes & Noble
Format:	eBook
File size:	16 MB
Note:	This product may take a few minutes to download.

Table of Contents

Clinical Implications of Genomic Profile in Waldenström Macroglobulinemia Frontline Management of Waldenström Macroglobulinemia with Chemoimmunotherapy Proteasome Inhibitor-Based Regimens in the Frontline Management of Waldenström Macroglobulinemia BTK Inhibitors in the Frontline Management of Waldenström Macroglobulinemia Future Directions in the Frontline Management of Waldenström Macroglobulinemia The Management of Relapsed or Refractory Waldenström’s Macroglobulinemia Novel Agents in Waldenström Macroglobulinemia Investigation and Management of Immunoglobulin M– and Waldenström-Associated Peripheral Neuropathies Evaluation and Management of Bing–Neel Syndrome Evaluation and Management of Disease Transformation in Waldenström Macroglobulinemia Management of Waldenström Macroglobulinemia in Limited-Resource Settings

What People are Saying About This

From the Publisher

Timely, relevant discussions on Waldenström macroglobulinemia